ArticleJournal of vascular surgery2026
Alcohol use disorder increases risk of major adverse limb events following lower-extremity revascularization for chronic limb-threatening ischemia.
Article in Journal of vascular surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveOne in four patients with chronic limb-threatening ischemia (CLTI) undergo major amputation. Despite an established pathophysiological link between excessive alcohol consumption and adverse cardiovascular outcomes, the prevalence and impact of alcohol use disorder (AUD) among adult patients with CLTI has not been investigated. To address this gap, we sought to evaluate the association between AUD and major adverse limb events (MALE) among adults undergoing lower extremity revascularization for CLTI.
methodsData were abstracted via Structured Query Language server queries of inpatient and outpatient electronic health records of the UPMC multi-hospital, unified health care system. We included index revascularization (endovascular or open) among adults with CLTI (2016-2024). Validated International Classification of Diseases, 10th Revision-Clinical Modification (ICD-10-CM) codes defined AUD. One-year outcomes of MALE (primary), major amputation, and major revascularization were compared with Fine-Gray regression risk-adjusted for competing mortality. Cumulative hazard curves and Cox modeling assessed these outcomes alongside 1-year mortality in sensitivity analyses. Multivariable regression was clustered by hospital and generated subdistribution (sHR) or adjusted (aHR) hazard ratios with 95% confidence intervals (CIs) for Fine-Gray or Cox modeling, respectively.
resultsAmong 3744 patients with CLTI undergoing revascularization (mean age, 69.8 ± 11.7 years; 61.0% male), 183 (4.9%) had an AUD diagnosis. Patients with an AUD diagnosis were more frequently male (84.2% vs 59.8%; P < .001) and concurrent tobacco users (56.3% vs 26.4%; P < .001). AUD correlated with an increased risk of 1-year MALE (35.6% vs 27.2%; P = .002). In Fine-Gray competing-mortality risk regression, AUD was independently associated with increased risk MALE (sHR, 1.29; 95% CI, 1.03-1.63; P = .029). Although major revascularization failed to reach significance (sHR, 1.14; 95% CI, 0.89-1.47; P = .295), AUD conferred higher 1-year risk of major amputation (sHR, 1.94; 95% CI, 1.65-2.36; P < .001) and mortality (aHR, 1.51; 95% CI, 1.09-2.09; P = .013).
conclusionsAn AUD diagnosis independently conferred greater risk of MALE and mortality among adults undergoing index lower extremity revascularization for CLTI. These findings underscore the potential value of preoperative identification of AUD to refine risk stratification in this vulnerable, understudied population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.